Chinook Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Chinook Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects (NCT05508204) | Chinook Therapeutics, Inc. | 2022-07-19 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy Volunteers (NCT05367661) | Chinook Therapeutics, Inc. | 2022-04-08 |
| Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) (NCT03340883) | Chinook Therapeutics, Inc. | 2017-11-15 |
Track Chinook Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.